Friday, July 10, 2026

Intelligence · Clinical pipeline

Autoimmune & immunology · Approved programs

Autoimmune & immunology programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs 84

Quick answer

Autoimmune & immunology Approved programs programs: NovaPharmaNews indexes 84 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

Page 2 of 2
  1. Prednisone

    Takeda

    Crohn's Disease

    approved small molecule terminated

    1 trial
  2. Purified Cortophin Gel, 40 U

    ANI PHARMACEUTICALS INC

    Gout Arthritis

    approved small molecule active

    1 trial
  3. RC-P0055

    The George Institute

    Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.

    approved small molecule active

    1 trial
  4. ROSUVASTATIN for CHRONIC INFLAMMATORY RHEUMATIC…

    The George Institute

    CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus

    approved small molecule active

    1 trial
  5. Re-JIA

    Istituto Gentili S.r.l.

    Juvenile idiopathic arthritis

    approved small molecule active

    1 trial
  6. Remsima 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Crohn's Disease

    approved small molecule active

    1 trial
  7. Rosuvastatin

    Hospital Authority, Hong Kong

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial
  8. Sarilumab

    Regeneron UK Limited

    Rheumatoid Arthritis

    approved small molecule terminated

    8 trials
  9. Sarilumab

    Regeneron UK Limited

    Polymyalgia Rheumatica

    approved small molecule active

    1 trial
  10. Saussurea Involucrata Liquid Tonic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postpartum Rheumatism

    approved small molecule active

    1 trial
  11. Spesolimab

    Boehringer Ingelheim

    Generalized Pustular Psoriasis

    approved small molecule active

    3 trials
  12. TARGET2020

    Sana Biotechnology

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial
  13. Tetanusvaccin, suspensie voor injectie 40 IE

    Disc Medicine

    Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis

    approved small molecule active

    1 trial
  14. Tofacitinib with methotrexate

    Pfizer

    Rhematoid Arthritis

    approved small molecule completed

    1 trial
  15. Treatment Algorithm A

    Takeda

    Colitis, Ulcerative

    approved mab active

    1 trial
  16. Triamcinolone acetonide-Ketorolac-Ropivacaine

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved small molecule active

    1 trial
  17. Triptergium Wilfordii

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis Vulgaris

    approved small molecule active

    1 trial
  18. Vedolizumab

    Takeda

    Crohn Disease

    approved small molecule terminated

    4 trials
  19. Vedolizumab

    Second Affiliated Hospital of Soochow University

    Ulcerative Colitis (UC)

    approved mab completed

    1 trial
  20. Vedolizumab

    Takeda

    Moderately to Severely Active Crohn's Disease

    approved mab active

    1 trial
  21. Vedolizumab

    Takeda

    Crohn's Disease

    approved small molecule active

    6 trials
  22. Vedolizumab 300 mg

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial
  23. Vedolizumab IV

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial
  24. Vyvgart 20 mg/mL concentrate for solution for infusion

    The George Institute

    Patients affected by generalized myasthenia gravis

    approved small molecule active

    1 trial
  25. Wangbi granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  26. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial
  27. Yuflyma solution for injection in pre-filled pen for Rheumatoid arthritis

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial
  28. Zushima plaster with high dose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoarthritis

    approved small molecule completed

    1 trial
  29. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial
  30. biologics treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis

    approved mab active

    1 trial
  31. fecal microbiota transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    approved small molecule active

    1 trial
  32. hyaluronic Acid + platelet-rich plasma

    Regeneron Ireland Designated Activity Company (DAC)

    Knee Osteoarthritis

    approved small molecule completed

    1 trial
  33. hylan G-F 20

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved other completed

    1 trial
  34. large protein molecule

    HALOZYME THERAPEUTICS, INC.

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial
  35. methotrexate (MTX)

    AbbVie

    Psoriatic Arthritis

    approved small molecule completed

    1 trial
  36. tacrolimus

    Chinese University of Hong Kong

    Lupus Nephritis

    approved small molecule completed

    1 trial

Frequently asked questions

How many autoimmune & immunology Approved programs programs exist?

84 programs match both the therapeutic area and stage filters in our published index.